Aspen Aerogels, Inc. (ASPN)

NYSE Currently up 0.10 (+2.77%) in today's trading session

1 member of Congress has disclosed 6 trades in Aspen Aerogels, Inc. (ASPN) via STOCK Act filings. The most recent disclosure was a sale by Debbie Wasserman Schultz on 22 November 2017. Aggregate disclosed activity totals roughly $32K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Aspen Aerogels, Inc. is currently trading at $3.71, positioned at 19% of its 52-week range ($2.30 – $9.78).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$3.71
24h Change
+0.10 (+2.77%)
52 Week Range
$2.30$9.78
View on NASDAQ

Aspen Aerogels, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ASPN

Select to highlight on chart
3 transactions
Compliance: 50%
Debbie Wasserman Schultz22 Nov 201729 Nov 2017SaleStock$1,001 - $15,000N/A
Debbie Wasserman Schultz19 Sept 201618 Oct 2016PurchaseStock$1,001 - $15,000N/A
Debbie Wasserman Schultz27 Apr 20166 Jul 2016PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$307.28M

Volume

2.13M

Beta

2.90

P/E Ratio

-0.78

Fundamentals

EPS

$-4.73

Div. Yield

Open

$3.57

Day Range

$3.56 — $3.73

Company Information

Sector
Industrials
Industry
Construction
Exchange
NYSE · USD
Country
US
CEO
Donald R. Young
IPO Date
2014-06-13

Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offer...

Earnings

Next Report

Q1 2026

7 May

EPS Est.

$-0.27

Rev. Est.

$36.6M

Days Until

6

Recent Quarters

Q4 202525 Feb
EPS$-0.34
Miss 25.9%
Q3 20256 Nov
EPS$-0.06
Beat 72.1%
Q2 20257 Aug
EPS$-0.04
Beat 66.7%
Q1 20258 May
EPS$-0.06
Beat 14.3%
Q4 202412 Feb
EPS$0.15
Beat 275.0%
Q3 20246 Nov
EPS$0.11
Beat 210.0%
Q2 20247 Aug
EPS$0.21
Beat 320.0%
Q1 20241 May
EPS$0.01
Beat 107.7%
Q4 202312 Feb
EPS$-0.01
Beat 91.7%
Q3 20231 Nov
EPS$-0.19
Beat 34.5%
Q2 20232 Aug
EPS$-0.22
Beat 38.9%
Q1 20233 May
EPS$-0.24
Beat 41.5%
Q4 202216 Feb
EPS$-0.20
Beat 33.3%
Q4 202215 Feb
EPS$-0.00
Q3 202226 Oct
EPS$-0.75
Miss 38.9%
Q2 202227 Jul
EPS$-0.68
Miss 19.3%
Q1 202227 Apr
EPS$-0.59
Miss 25.5%
Q4 202117 Feb
EPS$-0.50
Miss 66.7%
Q3 202128 Oct
EPS$-0.35
Miss 40.0%
Q2 202129 Jul
EPS$-0.23
Beat 17.9%
Q1 202129 Apr
EPS$-0.22
Miss 10.0%
Q4 202018 Feb
EPS$-0.23
Miss 53.3%
Q3 202029 Oct
EPS$-0.25
Miss 56.3%
Q2 202030 Jul
EPS$-0.21
Beat 0.0%
Q1 202030 Apr
EPS$-0.13
Beat 43.5%
Q4 201920 Feb
EPS$-0.04
Miss 4.8%
Q3 201931 Oct
EPS$-0.09
Beat 18.2%
Q2 20191 Aug
EPS$-0.22
Miss 37.5%
Q1 20192 May
EPS$-0.25
Beat 0.0%
Q4 201821 Feb
EPS$-0.35
Miss 337.5%
Q3 20181 Nov
EPS$-0.27
Miss 17.4%
Q2 20182 Aug
EPS$-0.29
Miss 26.1%
Q1 20183 May
EPS$-0.29
Miss 3.6%
Q4 201722 Feb
EPS$-0.07
Beat 46.1%
Q3 20172 Nov
EPS$-0.13
Beat 18.8%
Q2 20173 Aug
EPS$-0.23
Beat 11.5%
Q1 20174 May
EPS$-0.39
Miss 25.8%
Q4 201623 Feb
EPS$-0.25
Miss 47.1%
Q3 20163 Nov
EPS$-0.13
Miss 18.2%
Q2 20164 Aug
EPS$-0.06
Miss 20.0%
Q1 20165 May
EPS$-0.08
Miss 60.0%
Q4 201525 Feb
EPS$0.07
Beat 104.1%
Q3 20155 Nov
EPS$-0.11
Miss 57.1%
Q2 20156 Aug
EPS$-0.12
Beat 0.0%
Q1 20157 May
EPS$-0.12
Beat 20.0%
Q4 201426 Feb
EPS$-0.12
Beat 14.3%
Q3 20146 Nov
EPS$-0.10
Beat 28.6%
Q2 20147 Aug
EPS$-0.14
Beat 26.3%
Q4 201331 Mar
EPS$-0.83
Q3 201331 Dec
EPS$-0.74
Q2 201330 Sept
EPS$-0.55
Q1 201330 Jun
EPS$-0.83
Q4 201231 Mar
EPS$0.04
Q2 201230 Sept
EPS$-0.66
Q1 201130 Jun
EPS$-0.20
Q4 201031 Mar
EPS$-0.11
Q1 201030 Jun
EPS$-0.15
Q4 200931 Mar
EPS$-0.24

2 politicians traded within 30 days

Dividends

Dividend History

3 Dec 2009
Amount $0.7300
16 Nov 2006
Amount $0.0500

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NGD

New Gold Inc.

17
$9.08-0.39 (-4.12%)
Basic Materials
Held by same politician
1 politician
View Stock

VSAT

Viasat, Inc.

17
$65.91+6.63 (+11.18%)
Technology
Held by same politician
1 politician
View Stock

RELL

Richardson Electronics, Ltd.

17
$14.40+0.65 (+4.73%)
Technology
Held by same politician
1 politician
View Stock

Frequently Asked Questions about ASPN

Which members of Congress have traded ASPN?
1 member of Congress has disclosed 6 trade in Aspen Aerogels, Inc. (ASPN) under the STOCK Act: Debbie Wasserman Schultz.
When was ASPN most recently disclosed by Congress?
The most recent ASPN disclosure was a sale by Debbie Wasserman Schultz on 22 November 2017.
What is the total disclosed congressional trading volume for ASPN?
Members of Congress have disclosed approximately $32K in ASPN purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ASPN?
This ASPN page updates as soon as new STOCK Act disclosures are filed for Aspen Aerogels, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.